Tor Olofsson

affiliated with the university
More filtering options
  1. 2019
  2. Biological treatment of ankylosing spondylitis: A nationwide study of treatment trajectories on a patient level in clinical practice

    Lindström, U., Tor Olofsson, Wedrén, S., Qirjazo, I. & Askling, J., 2019, In : Arthritis Research and Therapy. 21, 1, 128.

    Research output: Contribution to journalArticle

  3. 2018
  4. Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: A population-based nationwide study

    Lindström, U., Tor Olofsson, Wedrén, S., Qirjazo, I. & Askling, J., 2018, In : RMD Open. 4, 2, e000762.

    Research output: Contribution to journalArticle

  5. 2017
  6. 2016
  7. Anti-TNF therapy in rheumatoid arthritis. Effects on and predictors of work disability

    Tor O Olofsson, 2016, Department of Clinical Sciences, Lund University. 108 p.

    Research output: ThesisDoctoral Thesis (compilation)

  8. 2015
  9. Does disease activity at start of biologic therapy influence work-loss in RA patients?

    Tor O Olofsson, Johansson, K., Eriksson, J. K., van Vollenhoven, R., Miller, H., Ingemar Petersson, Askling, J. & Neovius, M., 2015, In : Rheumatology (Oxford, England).

    Research output: Contribution to journalArticle

  10. 2014
  11. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

    Tor O Olofsson, Ingemar Petersson, Eriksson, J., Martin Englund, Simard, J. F., Nilsson, J-Å., Pierre Geborek, Lennart Jacobsson, Askling, J. & Neovius, M., 2014, In : Annals of the Rheumatic Diseases. 73, 5, p. 845-853

    Research output: Contribution to journalArticle